TIMP3 and neoplasm: With all aspects considered, this work bridges the gap between immune response and gene expression in colorectal cancer (CRC), expanding our knowledge of TIMP3 as a tumor suppressor and immune landscape regulator with potential implications for immunotherapeutic targeting.